Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
103.00    -1.50 (-1.44%)
Bid:
102.60
Ask:
103.10
Spread: 0.50 (0.487%)
Market Cap: £382.30m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Share Repurchase Programme

14 Jun 2023 07:00

RNS Number : 6159C
RWS Holdings PLC
14 June 2023
Ā 

For immediate release 14 June 2023

RWS Holdings plc

Share Repurchase Programme

As previously announced on 8 June 2023 in its half-year results for the six months ended 31 March 2023, RWS Holdings plc ("RWS" or the "Company") is today launching a share repurchase programme of up to £50 million to be executed by the Company's next Annual General Meeting, expected to be held in February 2024 (the "Repurchase Programme").

RWS will execute the Repurchase Programme in two tranches. In respect of the first tranche, RWS has today entered into a non-discretionary agreement with Numis Securities Limited ("Numis") to purchase RWS's ordinary shares of 1 pence each ("RWS Shares") for an aggregate value (excluding expenses) of up to £25 million pursuant to the Repurchase Programme (the "Initial Tranche"). Numis will act as riskless principal for the simultaneous on-sale of such RWS Shares to RWS and will make its trading decisions concerning the timing of the purchases of RWS Shares independently of and uninfluenced by RWS. Purchases of RWS Shares under the Initial Tranche will commence today and end no later than the date of the Company's next Annual General Meeting and will be carried out on the London Stock Exchange.

The second tranche of the Repurchase Programme will commence promptly once Numis has completed the Initial Tranche. For the purposes of effecting the second tranche, RWS has today entered into a non-discretionary agreement with Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg") to purchase further RWS Shares for an aggregate value (excluding expenses) of up to £25 million (the "Second Tranche"). Berenberg will undertake the Second Tranche on the same terms as Numis and will only commence share repurchases once the Initial Tranche has been completed. Purchases under the Second Tranche will end no later than the date of the Company's next Annual General Meeting.

The aggregate purchase price of RWS Shares purchased by Numis and Berenberg under the Repurchase Agreement will not exceed £50 million (exclusive of expenses). The purpose of the Repurchase Programme is to reduce the share capital of RWS. To the extent permitted by law, all RWS Shares purchased under the Repurchase Programme will be cancelled.

The Repurchase Programme will be conducted within certain pre-set parameters, and in accordance with the general authority to repurchase shares granted by RWS's shareholders at the 2023 Annual General Meeting and with the EU Market Abuse Regulation (596/2014) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), the Commission Delegated Regulation (EU) 2016/1052 (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) and the AIM Rules.

The maximum number of RWS Shares which may be purchased by RWS under the Repurchase Programme is 38,946,009, which is the maximum number permitted pursuant to the authority granted by RWS's shareholders at the 2023 Annual General Meeting.

RWS will announce any market repurchases of RWS Shares no later than 7.30 a.m. on the business day following the date on which the repurchase occurred.

For further information, please contact:

RWS Holdings plc

Andrew Brode, Chairman

Ian El-Mokadem, Chief Executive Officer

Candida Davies, Chief Financial Officer

Ā 

Ā 

Ā 

01753 480200

Ā 

MHP (Financial PR Advisor)

Katie Hunt / Eleni Menikou / Catherine Chapman

Ā 

rws@mhpc.com

020 3128 8100

07884 494112

Ā 

Numis (Nomad & Joint Broker)

Stuart Skinner / Kevin Cruickshank / Will Baunton

Ā 

Ā 

Ā 

020 7260 1000

Ā 

Berenberg (Joint Broker)

Ben Wright / Toby Flaux / Alix Mecklenburg-Solodkoff

Ā 

020 3207 7800

Ā 

About RWS:

RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our combination of AI-enabled technology and human expertise helps our clients to grow by ensuring they are understood anywhere, in any language.

Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.

Over the past 20 years we've been evolving our own AI solutions as well as helping clients to explore, build and use multilingual AI applications. With 40+ AI-related patents and more than 100 peer-reviewed papers, we have the experience and expertise to support clients on their AI journey.

We work with over 80% of the world's top 100 brands, more than three-quarters of Fortune's 20 'Most Admired Companies' and almost all of the top pharmaceutical companies, investment banks, law firms and patent filers. Our client base spans Europe, Asia Pacific and North and South America. Our 65+ global locations across five continents service clients in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors.

Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L).

For further information, please visit: www.rws.com.

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
POSNKNBPCBKDFAD
Date   Source Headline
9th Jan 20259:10 amRNSPublication of Annual Report and Notice of AGM
6th Jan 20259:00 amRNSAppointment of Director
2nd Jan 20257:00 amRNSTotal Voting Rights
12th Dec 20247:00 amRNSFinal Results
2nd Dec 20247:00 amRNSTotal Voting Rights
26th Nov 20247:00 amRNSDirectorate Change
1st Nov 20247:00 amRNSTotal Voting Rights
31st Oct 202410:12 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSTrading Statement
1st Oct 20247:00 amRNSDirectorate Change
1st Oct 20247:00 amRNSTotal Voting Rights
24th Sep 20247:00 amRNSDirector/PDMR Shareholding
2nd Sep 20247:00 amRNSTotal Voting Rights
13th Aug 202411:15 amRNSHolding(s) in Company
1st Aug 20249:21 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTotal Voting Rights
21st Jun 20249:58 amRNSDirector/PDMR Shareholding
12th Jun 20249:50 amRNSDirector/PDMR Shareholding
12th Jun 20247:00 amRNSHalf-year Report
3rd Jun 20247:00 amRNSTotal Voting Rights
23rd May 20247:00 amRNSDirectorate Change
1st May 20247:00 amRNSTotal Voting Rights
23rd Apr 20247:00 amRNSTrading Statement
2nd Apr 20247:00 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTotal Voting Rights
23rd Feb 20247:00 amRNSHolding(s) in Company
22nd Feb 20241:01 pmRNSResult of AGM
22nd Feb 20247:00 amRNSClosing of Share Repurchase Programme
22nd Feb 20247:00 amRNSAGM Statement
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20249:33 amRNSHolding(s) in Company
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20248:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.